Join us on the Cipla Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock. Stay in ...

Cipla has announced that the United States Food and Drug Administration (USFDA) has classified its recent inspection of the company's manufacturing facility in Bommasandra, Bengaluru as Voluntary ...

Mumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the current Good ...

AI-powered recruitment platform TurboHire raises $6 mn in Series A led by IvyCap Ventures to scale global growth and enhance ...

Eris Lifesciences is using its growing insulin business to position itself as a serious contender in India’s fast-expanding ...

Biocon and Aurobindo Pharma are identified as facing significant EPS impacts within the generics and biosimilars domain.

Welcome to the Cipla Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ...

Alembic Pharmaceuticals reports 14.6% profit rise in Q1, driven by strong U.S. and India sales, launching 4 new products.

With this funding, Hyderabad-based TurboHire plans to scale its global expansion, enhance its AI-driven recruitment platform, ...

The market for chronic obstructive pulmonary disease treatment devices is projected to witness substantial growth, fueled by several major drivers. The rising incidence of chronic obstructive ...

India's Alembic Pharmaceuticals reported a 14.6% rise in consolidated profit for the first quarter on Tuesday, driven by strong sales in the U.S. and India. The firm's consolidated profit rose to 1.54 ...

The India-United Kingdom Comprehensive Economic and Trade Agreement, or CETA, raises several questions regarding India’s ...